Table 3.
Pearson’s correlation among serum levels of UA, sMICA and sMICB in all subjects with pancreatic carcinogenesis (A) and overt pancreatic ductal adenocarcinoma (B)
| UA | sMICA | sMICB | CA19‐9 | |
|---|---|---|---|---|
| γp (P‐value) | γp (P‐value) | γp (P‐value) | γp (P‐value) | |
| (A) | ||||
| UA | – | −0.441 (0.001) | −0.360 (0.002) | −0.221 (0.020) |
| sMICA | −0.441 (0.001) | – | 0.919 (0.001) | 0.473 (0.001) |
| sMICB | −0.360 (0.002) | 0.919 (0.001) | – | 0.508 (0.001) |
| CA19‐9 | −0.221 (0.020) | 0.473 (0.001) | 0.508 (0.001) | – |
| (B) | ||||
| UA | – | −0.328 (0.023) | −0.751 (0.008) | −0.069 (0.648) |
| sMICA | −0.328 (0.023) | – | 0.857 (0.001) | 0.317 (0.027) |
| sMICB | −0.751 (0.008) | 0.857 (0.001) | – | 0.347 (0.245) |
| CA19‐9 | −0.069 (0.648) | 0.317 (0.027) | 0.347 (0.245) | – |
γp, Pearson correlation coefficient; CA19‐9, cancer antigen 19‐9; sMICA, soluble MHC class I chain‐related molecules A; sMICB, soluble MHC class I chain‐related molecules B; UA, uric acid. Values in bold font are statistically significant.